Keebeck Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377K Buy
13,408
+4,445
+50% +$118K 0.04% 271
2025
Q4
$223K Buy
+8,963
New +$226K 0.03% 348
2024
Q4
Sell
-13,748
Closed -$398K 293
2024
Q3
$398K Buy
13,748
+110
+0.8% +$3.21K 0.06% 189
2024
Q2
$382K Buy
13,638
+323
+2% +$8.89K 0.06% 194
2024
Q1
$369K Buy
+13,315
New +$369K 0.05% 213
2023
Q4
Sell
-6,119
Closed -$203K 277
2023
Q3
$203K Sell
6,119
-65
-1% -$2.3K 0.04% 247
2023
Q2
$227K Hold
6,184
0.03% 247
2023
Q1
$252K Hold
6,184
0.04% 223
2022
Q4
$317K Sell
6,184
-30
-0.5% -$1.44K 0.06% 190
2022
Q3
$272K Sell
6,214
-940
-13% -$45.7K 0.05% 199
2022
Q2
$375K Buy
7,154
+1,182
+20% +$60.2K 0.07% 175
2022
Q1
$309K Hold
5,972
0.05% 197
2021
Q4
$353K Buy
5,972
+544
+10% +$27K 0.06% 174
2021
Q3
$233K Sell
5,428
-3,855
-42% -$171K 0.05% 193
2021
Q2
$364K Hold
9,283
0.05% 192
2021
Q1
$336K Hold
9,283
0.05% 190
2020
Q4
$342K Buy
9,283
+2,624
+39% +$96.2K 0.06% 168
2020
Q3
$231K Buy
6,659
+938
+16% +$32.9K 0.05% 171
2020
Q2
$177K Buy
+5,721
New +$194K 0.06% 161
2020
Q1
Sell
-6,452
Closed -$239K 280
2019
Q4
$239K Buy
+6,452
New +$230K 0.08% 133

Other funds holding PFE

Keebeck Wealth Management's PFE Position: Q1 2026 in Review

Keebeck Wealth Management increased its Pfizer (PFE) stake by 50% in Q1 2026, buying an estimated $118K and bringing the position to 13,408 shares worth $377K. The position accounts for 0.04% of the portfolio, ranked #271.

Keebeck Wealth Management first reported a position in PFE in Q4 2019 and has held it in 20 quarters since. The position peaked at $398K in Q3 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Keebeck Wealth Management held 13,408 shares of Pfizer worth $377K as of Q1 2026.
  • Keebeck Wealth Management bought 4,445 Pfizer shares in Q1 2026, an estimated $118K.
  • Pfizer made up 0.04% of Keebeck Wealth Management's portfolio in Q1 2026, its #271 holding.
  • Keebeck Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 20 quarters since.
  • Keebeck Wealth Management's Pfizer position peaked at $398K in Q3 2024.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Keebeck Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.